BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21387717)

  • 1. [Chronic hepatitis C: current treatment and perspectives].
    Negro F
    Rev Med Suisse; 2011 Jan; 7(279):212-3. PubMed ID: 21387717
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Towards the eradication of hepatitis C virus.
    Marcellin P; Asselah T
    Liver Int; 2012 Feb; 32 Suppl 1():1. PubMed ID: 22212564
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial watch: Protease inhibitors show promise against HCV.
    Nat Rev Drug Discov; 2009 Jan; 8(1):11. PubMed ID: 19116621
    [No Abstract]   [Full Text] [Related]  

  • 4. "Strong reasons make strong actions"--The antiviral efficacy of NS3/4A protease inhibitors.
    Lemon SM; Yi M; Li K
    Hepatology; 2005 Mar; 41(3):671-4. PubMed ID: 15723328
    [No Abstract]   [Full Text] [Related]  

  • 5. Boceprevir.
    Maddur H; Kwo PY
    Hepatology; 2011 Dec; 54(6):2254-7. PubMed ID: 22095684
    [No Abstract]   [Full Text] [Related]  

  • 6. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecule of the month. Telaprevir.
    Drug News Perspect; 2010 Jun; 23(5):329. PubMed ID: 20603656
    [No Abstract]   [Full Text] [Related]  

  • 8. Telaprevir: a new hope in the treatment of chronic hepatitis C?
    Fowell AJ; Nash KL
    Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
    Herrmann E; Zeuzem S; Sarrazin C; Hinrichsen H; Benhamou Y; Manns MP; Reiser M; Reesink H; Calleja JL; Forns X; Steinmann GG; Nehmiz G
    Antivir Ther; 2006; 11(3):371-6. PubMed ID: 16759054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of chronic hepatitis C in 2008].
    Pol S; Marcellin P
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S121-4. PubMed ID: 18675182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic viral hepatitis C: current therapy and perspectives].
    Couzigou P; De Ledinghen V; Foucher J
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B135-42. PubMed ID: 11449154
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
    Douglas SD
    Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
    Tang J; Kaslow RA
    Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
    Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment of chronic hepatitis C].
    Svirtlih N; Simović-Babić J; Krstić M; Delić D
    Srp Arh Celok Lek; 2005; 133(3-4):202-7. PubMed ID: 16206713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis].
    Friedrich-Rust M; Forestier N; Zeuzem S
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S229-30. PubMed ID: 16435720
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C: current and future therapies.
    Mishra P; Jensen DM
    Mt Sinai J Med; 2008 Aug; 75(4):405-14. PubMed ID: 18729159
    [No Abstract]   [Full Text] [Related]  

  • 19. Future treatment of chronic hepatitis C.
    Keeffe EB
    Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An update on the management of chronic hepatitis C].
    Bihl F; Pache I; Hess J; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):174, 176-9. PubMed ID: 20214188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.